420 LEXINGTON AVE,, NEW YORK, NY
Market cap: $269.4M (8/06/2024)
Price: $40.50
Reports Fiscal Year 2025 Financial Results and Provides Business Update
Announces Closing of $18 Million Concurrent Registered Direct Offering and Private Placement Priced At-The-Market Under Nasdaq Rules
Announces U.S. Commercial Launch of LYMPHIR™, a Novel Cancer Immunotherapy for Cutaneous T-Cell Lymphoma (CTCL)
Citius Oncology Approves Amendment to 2024 Omnibus Stock Incentive Plan
Corporate Overview October 2025
News, Material Contracts
Announces Closing of $9.0 Million Registered Direct Offering and Concurrent Private Placement
Other Events
FY 2024
Q2
Q1
Q4
Amended Annual Report
FY 2023
Prospectus filed pursuant to Rule 424(b)(5)
Registration Statement for Securities to be Offered to Employees
Prospectus filed pursuant to Rule 424(b)(3)
Effectiveness Notice
Registration Statement for Securities Offered under a Shelf Registration
Definitive Proxy Statement
Definitive Additional Proxy Soliciting Materials
Definitive Information Statement
Preliminary Information Statement
Additional Proxy Materials
PRE 14A
Amended Statement of Changes in Beneficial Ownership
Submission Upload
Correspondence